SAFETY AND EFFICACY

Clinical trials for SAFETY AND EFFICACY explained in plain language.

Never miss a new study

Get alerted when new SAFETY AND EFFICACY trials appear

Sign up with your email to follow new studies for SAFETY AND EFFICACY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 1

Engineered immune cells take aim at Hard-to-Treat multiple myeloma

Disease control Ongoing

This study tests whether giving patients with high-risk multiple myeloma specially engineered T-cells (CAR T-cells) after a stem cell transplant can safely improve outcomes. The T-cells are designed to target two proteins on myeloma cells, CD19 and BCMA. Researchers are monitorin…

Matched conditions: SAFETY AND EFFICACY

Phase: PHASE1, PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control

Last updated Jun 27, 2026 11:02 UTC

SAFETY AND EFFICACY

Get alerted when new SAFETY AND EFFICACY trials appear

Engineered immune cells take aim at Hard-to-Treat multiple myeloma